Back to All

Notice of Capital Markets Day

7 June, 2021

Diaceutics PLC 

("Diaceutics" or "the Group")

Notice of Capital Markets Day

Diaceutics PLC (AIM: DXRX), the diagnostic commercialisation company, announces that it will be hosting a virtual Capital Markets Day ("CMD") for investors and equity analysts on Wednesday 16th June 2021, starting at 13:00pm BST.

The event will be hosted by Group CEO, Peter Keeling, and will include a series of presentations, a demonstration of the DXRX SaaS platform, views from an industry expert panel including:

  • Pharmaceutical Partner: a senior executive within one of the world’s top five pharmaceutical companies
  • Laboratory Partner: Professor Giancarlo Pruneri, Head of Pathology Fondazione IRCCS Istituto Nazionale Tumori, Milan
  • Key Opinion Leader: Dr Avi Kulkarni, SVP and R&D leader at Nasdaq listed technology firm Cognizant

In addition, there will be a strategic update from the Company, along with a live Q&A.

A video replay of the presentation will be available via the Group's website post-event.

If you are interested in attending or have any questions relating to the Diaceutics Capital Markets Day please contact [email protected]

Enquiries:

Diaceutics PLC

Peter Keeling, Chief Executive Officer

Philip White, Chief Financial Officer

 

www.diaceutics.com

via Alma PR

Stifel Nicolaus Europe Limited (Nominated Adviser and Broker)

Ben Maddison

Stewart Wallace

Nick Adams

+44 (0)20 7710 7600

Alma PR

Caroline Forde

Robyn Fisher

Kieran Breheny

Tel: +44 (0)20 3405 0205

[email protected]

About Diaceutics

At Diaceutics we believe that every patient should have access to the right treatment at the right time. We provide the world’s leading pharmaceutical companies with an end-to-end solution for the launch of precision medicine diagnostics enabled by DXRX – The Diagnostic Network®.

DXRX is the world’s first diagnostic commercialisation platform for precision medicine, integrating multiple pipelines of real-world diagnostic testing data from a global network of laboratories.

About Diaceutics

At Diaceutics we believe that every patient should get the precision medicine they deserve. We are a data analytics and end-to-end services provider enabled by DXRX - the world’s first Network solution for the development and commercialization of precision medicine diagnostics. 

Diaceutics has worked on every precision medicine brought to market and provides services to 36 of the world’s leading pharmaceutical companies. We have built the world’s largest repository of diagnostic testing data with a growing network of 2500 labs in 51 countries.

Diaceutics PLC


Philip White
Chief Financial Officer
+44 (0) 7801 611 921


Nominated adviser and broker

Stifel Nicolaus Europe Limited
150 Cheapside
London
EC2V 6ET.

Public Relations & Investor Relations advisers

Alma PR
71-73 Carter Lane
London
EC4V 5EQ.

Tel: +44 (0)20 3405 0205 or [email protected]


 
Caroline Forde
Robyn Fisher
 
Kieran Breheny